Payment overview · 2025
General Payments
$67.66
3 reported records · 1 companies
Healthcare provider profile · identity verified
Eric Flegel, DO
Allopathic & Osteopathic Physicians|Family Medicine · TULSA, OK · NPI 1346292976
Verified facts
What the public records show
CMS Open Payments records show Eric Flegel, DO received $67.66 in general payments during 2025 across 3 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $67.66 | 100.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $67.66 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $67.66 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 654 | 101 |
| Amlodipine Besylate | Amlodipine Besylate | 570 | 108 |
| Gabapentin | Gabapentin | 521 | 86 |
| Atorvastatin Calcium | Atorvastatin Calcium | 517 | 105 |
| Pantoprazole Sodium | Pantoprazole Sodium | 482 | 88 |
| Lisinopril | Lisinopril | 413 | 72 |
| Donepezil Hcl | Donepezil Hcl | 394 | 76 |
| Potassium Chloride | Potassium Chloride | 358 | 79 |
| Trazodone Hcl | Trazodone Hcl | 289 | 66 |
| Metoprolol Tartrate | Metoprolol Tartrate | 276 | 56 |
| Memantine Hcl | Memantine Hcl | 267 | 52 |
| Losartan Potassium | Losartan Potassium | 264 | 52 |
| Omeprazole | Omeprazole | 250 | 46 |
| Eliquis | Apixaban | 244 | 52 |
| Furosemide | Furosemide | 233 | 59 |
| Sertraline Hcl | Sertraline Hcl | 233 | 49 |
| Escitalopram Oxalate | Escitalopram Oxalate | 231 | 58 |
| Hydrochlorothiazide | Hydrochlorothiazide | 228 | 47 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 215 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 204 | 43 |
| Quetiapine Fumarate | Quetiapine Fumarate | 200 | 57 |
| Carvedilol | Carvedilol | 183 | 40 |
| Mirtazapine | Mirtazapine | 180 | 43 |
| Tramadol Hcl | Tramadol Hcl | 165 | 57 |
| Famotidine | Famotidine | 159 | 29 |
| Buspirone Hcl | Buspirone Hcl | 150 | 41 |
| Metoprolol Succinate | Metoprolol Succinate | 146 | 36 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 133 | 95 |
| Clopidogrel | Clopidogrel Bisulfate | 132 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 130 | 28 |
| Spironolactone | Spironolactone | 128 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 127 | 36 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 120 | 41 |
| Pravastatin Sodium | Pravastatin Sodium | 118 | 24 |
| Simvastatin | Simvastatin | 117 | 23 |
| Metformin Hcl | Metformin Hcl | 115 | 23 |
| Alprazolam | Alprazolam | 114 | 47 |
| Glipizide | Glipizide | 92 | 17 |
| Alendronate Sodium | Alendronate Sodium | 91 | 16 |
| Bumetanide | Bumetanide | 91 | 21 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 86 | 12 |
| Sucralfate | Sucralfate | 86 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 81 | 21 |
| Bupropion Xl | Bupropion Hcl | 77 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 74 | 21 |
| Montelukast Sodium | Montelukast Sodium | 74 | 16 |
| Allopurinol | Allopurinol | 73 | 15 |
| Ondansetron Odt | Ondansetron | 73 | 50 |
| Levetiracetam | Levetiracetam | 71 | 11 |
| Nystatin | Nystatin | 71 | 34 |
| Torsemide | Torsemide | 66 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 65 | 51 |
| Xarelto | Rivaroxaban | 65 | 17 |
| Myrbetriq | Mirabegron | 64 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 62 | 14 |
| Meloxicam | Meloxicam | 62 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 61 | 13 |
| Latanoprost | Latanoprost | 60 | 12 |
| Metformin Hcl Er | Metformin Hcl | 60 | 13 |
| Azithromycin | Azithromycin | 59 | 50 |
| Aripiprazole | Aripiprazole | 56 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 56 | suppressed |
| Cephalexin | Cephalexin | 53 | 32 |
| Fluoxetine Hcl | Fluoxetine Hcl | 53 | 13 |
| Celecoxib | Celecoxib | 51 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 51 | 11 |
| Finasteride | Finasteride | 50 | 11 |
| Lorazepam | Lorazepam | 50 | 15 |
| Estradiol | Estradiol | 49 | 14 |
| Ezetimibe | Ezetimibe | 49 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 47 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 47 | 27 |
| Oxybutynin Chloride | Oxybutynin Chloride | 47 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 45 | 18 |
| Olanzapine | Olanzapine | 45 | 11 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 43 | 27 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 43 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | 14 |
| Atenolol | Atenolol | 38 | suppressed |
| Carbamazepine | Carbamazepine | 38 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 37 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 36 | 12 |
| Divalproex Sodium | Divalproex Sodium | 35 | suppressed |
| Irbesartan | Irbesartan | 35 | suppressed |
| Mupirocin | Mupirocin | 35 | 17 |
| Risperidone | Risperidone | 35 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 34 | 14 |
| Loperamide | Loperamide Hcl | 34 | 28 |
| Pioglitazone Hcl | Pioglitazone Hcl | 34 | suppressed |
| Pregabalin | Pregabalin | 33 | 11 |
| Primidone | Primidone | 33 | suppressed |
| Clonazepam | Clonazepam | 32 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 31 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 30 | suppressed |
| Glimepiride | Glimepiride | 30 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 29 | 29 |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 28 | suppressed |
| Baclofen | Baclofen | 28 | suppressed |
| Valsartan | Valsartan | 28 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 27 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 20 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Nystop | Nystatin | 25 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 24 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 23 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 23 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Lactulose | Lactulose | 22 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 22 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 21 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 19 |
| Perphenazine | Perphenazine | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 20 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 20 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 19 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 19 | suppressed |
| Cimetidine | Cimetidine | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 19 | suppressed |
| Fluconazole | Fluconazole | 19 | 16 |
| Glipizide Er | Glipizide | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Temazepam | Temazepam | 19 | suppressed |
| Amantadine | Amantadine Hcl | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 18 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 16 | suppressed |
| Gemtesa | Vibegron | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 16 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 16 | suppressed |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Trospium Chloride | Trospium Chloride | 16 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Methotrexate | Methotrexate Sodium | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Restasis | Cyclosporine | 13 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Enulose | Lactulose | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Klor-Con 8 | Potassium Chloride | 12 | suppressed |
| Prednisone | Prednisone | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Ramelteon | Ramelteon | 12 | suppressed |
| Trandolapril | Trandolapril | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Chlorzoxazone | Chlorzoxazone | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 11 | suppressed |
| Ofloxacin | Ofloxacin | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $67.66 · 3 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error